Related references
Note: Only part of the references are listed.B cells and antibodies in progressive multiple sclerosis: Contribution to neurodegeneration and progression
Judith Fraussen et al.
AUTOIMMUNITY REVIEWS (2016)
Therapeutic strategies targeting B-cells in multiple sclerosis
Ron Milo
AUTOIMMUNITY REVIEWS (2016)
Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination
Sudarshini Ramanathan et al.
AUTOIMMUNITY REVIEWS (2016)
Pharmacological profile of MEDI-551, a novel anti-CD19 antibody, in human CD19 transgenic mice
Sandra Gallagher et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis
Ding Chen et al.
JOURNAL OF IMMUNOLOGY (2016)
Features of Human CD3+CD20+ T Cells
Elisabeth Schuh et al.
JOURNAL OF IMMUNOLOGY (2016)
Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells
Sarantis Korniotis et al.
Nature Communications (2016)
MEDI-551 Treatment Effectively Depletes B Cells and Reduces Serum Titers of Autoantibodies in Mice Transgenic for Sle1 and Human CD19
Sandra Gallagher et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Meningeal Tertiary Lymphoid Tissues and Multiple Sclerosis: A Gathering Place for Diverse Types of immune Cells during CNS Autoimmunity
Natalia B. Pikor et al.
FRONTIERS IN IMMUNOLOGY (2016)
The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives
Michalina Jasiak-Zatonska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study
Elena Schiopu et al.
ARTHRITIS RESEARCH & THERAPY (2016)
A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow
Henrik E. Mei et al.
BLOOD (2015)
Long-Lived Plasma Cells Are Contained within the CD19-CD38hiCD138+ Subset in Human Bone Marrow
Jessica L. Halliley et al.
IMMUNITY (2015)
Biological Perspectives Anti-NMDA Receptor Encephalitis
Jonathan S. Dowben et al.
PERSPECTIVES IN PSYCHIATRIC CARE (2015)
Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond
Jennifer L. Kruse et al.
PSYCHOSOMATICS (2015)
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy
Rui Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage
Andrew L. Croxford et al.
TRENDS IN IMMUNOLOGY (2015)
B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized inflammation
Laure Michel et al.
FRONTIERS IN IMMUNOLOGY (2015)
B lymphocytes in neuromyelitis optica
Jeffrey L. Bennett et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis
Jeffrey T. Guptill et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Immunology of Relapse and Remission in Multiple Sclerosis
Lawrence Steinman
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis
Laure Michel et al.
CLINICAL IMMUNOLOGY (2014)
Clinical and scientific aspects of acetylcholine receptor myasthenia gravis
Marlies Keijzers et al.
CURRENT OPINION IN NEUROLOGY (2014)
Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord while Preserving Peripheral Regulatory Mechanisms
Ding Chen et al.
JOURNAL OF IMMUNOLOGY (2014)
B Cell Depletion Curtails CD4+ T Cell Memory and Reduces Protection against Disseminating Virus Infection
Ichiro Misumi et al.
JOURNAL OF IMMUNOLOGY (2014)
Complement activation in patients with neuromyelitis optica
Petra Nytrova et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
INTERLEUKIN-10 PRODUCING- B CELLS AND THEIR ASSOCIATION WITH RESPONSIVENESS TO RITUXIMAB IN MYASTHENIA GRAVIS
Feng Sun et al.
MUSCLE & NERVE (2014)
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
Ping Shen et al.
NATURE (2014)
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease
Russell C. Dale et al.
NEUROLOGY (2014)
Germinal Center B Cell Depletion Diminishes CD4+ Follicular T Helper Cells in Autoimmune Mice
Isharat Yusuf et al.
PLOS ONE (2014)
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells
Rebecca Noster et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Rationale for B cell targeting in SLE
Inaki Sanz
SEMINARS IN IMMUNOPATHOLOGY (2014)
The Plasma Cell Signature in Autoimmune Disease
Katie Streicher et al.
ARTHRITIS & RHEUMATOLOGY (2014)
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
Nicolas Molnarfi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis
Dilip K. Challa et al.
MABS (2013)
Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis
Chao Quan et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
B-cell targeted therapeutics in clinical development
Stephan Blueml et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges
Klaus Lehmann-Horn et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)
Long-lived plasma cells in autoimmunity: lessons from B-cell cepleting therapy
Matthieu Mahevas et al.
FRONTIERS IN IMMUNOLOGY (2013)
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss
Julien Ratelade et al.
ACTA NEUROPATHOLOGICA (2012)
Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate
Wolfgang Brueck et al.
ANNALS OF NEUROLOGY (2012)
Antibody-independent B cell effector functions in relapsing remitting Multiple Sclerosis: Clues to increased inflammatory and reduced regulatory B cell capacity
Sara J. Ireland et al.
AUTOIMMUNITY (2012)
CD19 as an attractive target for antibody-based therapy
Ohad Hammer
MABS (2012)
B cells and antibodies in multiple sclerosis pathogenesis and therapy
Markus Krumbholz et al.
NATURE REVIEWS NEUROLOGY (2012)
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
Shannon R. Hinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The role of antibodies in multiple sclerosis
Martin S. Weber et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
Yohei Iwata et al.
BLOOD (2011)
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
Cris S. Constantinescu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission
Stephanie Knippenberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
Klaus Lehmann-Horn et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Rituximab Therapy Reduces Organ-Specific T Cell Responses and Ameliorates Experimental Autoimmune Encephalomyelitis
Nancy L. Monson et al.
PLOS ONE (2011)
B-Cell Activation Influences T-Cell Polarization and Outcome of Anti-CD20 B-Cell Depletion in Central Nervous System Autoimmunity
Martin S. Weber et al.
ANNALS OF NEUROLOGY (2010)
Enhanced IL-6 Production in Aquaporin-4 Antibody Positive Neuromyelitis Optica Patients
Sema Icoz et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2010)
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
Ethan G. Hughes et al.
JOURNAL OF NEUROSCIENCE (2010)
B-Cell Depletion In Vitro and In Vivo with an Afucosylated Anti-CD19 Antibody
Ronald Herbst et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Antibodies Produced by Clonally Expanded Plasma Cells in Multiple Sclerosis Cerebrospinal Fluid
Gregory P. Owens et al.
ANNALS OF NEUROLOGY (2009)
CD19: a promising B cell target for rheumatoid arthritis
Thomas F. Tedder
NATURE REVIEWS RHEUMATOLOGY (2009)
Cytokine-producing B lymphocytes - key regulators of immunity
Frances E. Lund
CURRENT OPINION IN IMMUNOLOGY (2008)
A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses
Koichi Yanaba et al.
IMMUNITY (2008)
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Takashi Matsushita et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology
Roberta Magliozzi et al.
BRAIN (2007)
Myelin oligodendrocyte glycoprote in-specific T and B cells cooperate to induce a Devic-like disease in mice
Estelle Bettelli et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell B cell cooperation
Gurumoorthy Krishnamoorthy et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease
N Yazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis
B Serafini et al.
BRAIN PATHOLOGY (2004)
Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice
J Tian et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
